Atlas Trials

Wu Jun

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Wu Jun

RecordFirmDate
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study (NCT06241469)Wu Jun2024-02-03
Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Study (NCT05721651)Wu Jun2023-04-01

Track Wu Jun automatically

Every clearance here is in the API, with alerts when new ones post.